HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GS-236-0103 Study Team Selected Research

Emtricitabine (Emtriva)

3/2014A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results.
4/2013A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.
6/2012Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


GS-236-0103 Study Team Research Topics

Disease

3Infections
03/2014 - 06/2012

Drug/Important Bio-Agent (IBA)

3Ritonavir (Norvir)FDA Link
03/2014 - 06/2012
3Emtricitabine (Emtriva)FDA Link
03/2014 - 06/2012
3Tenofovir (Viread)FDA Link
03/2014 - 06/2012
3Atazanavir Sulfate (Reyataz)FDA Link
03/2014 - 06/2012
2CobicistatIBA
03/2014 - 04/2013
2elvitegravirIBA
03/2014 - 04/2013
1TabletsIBA
03/2014
1RacivirIBA
06/2012
1Protease Inhibitors (Protease Inhibitor)IBA
06/2012
1Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine Cobicistat ElvitegravirIBA
06/2012

Therapy/Procedure

1Therapeutics
06/2012